Company intelligence / Profile preview

Cenra Inc.

Ownership: Public · 3716
Development stage: Commercial

Overview

Cenra Inc. is an established Taiwanese pharmaceutical company engaged in the R&D, manufacture, and sale of generic pharmaceuticals, active pharmaceutical ingredients, over-the-counter drugs, self-care/home care/cosmetic products for humans as well as animal healthcare products. The company also provides contract manufacturing services and senior care services. It operates internationally with a commercial portfolio rather than novel clinical-stage assets.

Therapeutic areas: Other
Modalities: Small molecules (generic drugs)Active pharmaceutical ingredients (APIs)Over-the-counter drugsSelf-care and home care productsAnimal health products
Industry: Contract Manufacturing Organization

Drug pipeline

1 asset

Spikevax

Commercial

Indications: COVID-19

Beyond the preview

Go deeper on Cenra Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cenra Inc..

Explore the full profile